<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/25/1995-1191-2021-4-110-118</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-1391</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Регенеративная медицина и клеточные технологии</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Regenerative Medicine and Cell Technologies</subject></subj-group></article-categories><title-group><article-title>Роль апоптотических клеток костного мозга при активации регенерационных процессов в печени</article-title><trans-title-group xml:lang="en"><trans-title>The role of apoptotic bone marrow cells in activation of liver regeneration</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Онищенко</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Onishchenko</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никольская</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolskaya</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гоникова</surname><given-names>З. З.</given-names></name><name name-style="western" xml:lang="en"><surname>Gonikova</surname><given-names>Z. Z.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гоникова Залина Залимгериевна</p><p>123182, Москва, ул. Щукинская, д. 1</p><p>Тел. (966) 188-33-33</p></bio><bio xml:lang="en"><p>Zalina Gonikova</p><p>1, Shchukinskaya str., Moscow, 123182, Russian Federation</p><p>Phone: (966) 188-33-33</p></bio><email xlink:type="simple">zalina3392@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кирсанова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirsanova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шагидулин</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shagidulin</surname><given-names>M. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Севастьянов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sevastianov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Shumakov National Medical Research Center of Transplantology and Artificial Organs</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Shumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>22</day><month>10</month><year>2021</year></pub-date><volume>23</volume><issue>4</issue><fpage>110</fpage><lpage>118</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Онищенко Н.А., Никольская А.О., Гоникова З.З., Кирсанова Л.А., Шагидулин М.Ю., Севастьянов В.И., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Онищенко Н.А., Никольская А.О., Гоникова З.З., Кирсанова Л.А., Шагидулин М.Ю., Севастьянов В.И.</copyright-holder><copyright-holder xml:lang="en">Onishchenko N.A., Nikolskaya A.O., Gonikova Z.Z., Kirsanova L.A., Shagidulin M.Y., Sevastianov V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/1391">https://journal.transpl.ru/vtio/article/view/1391</self-uri><abstract><sec><title>Цель</title><p>Цель. На модели адоптивного переноса изучить клеточные механизмы формирования начальной стадии регенерационных процессов в печени при внутрибрюшинном введении здоровому реципиенту апоптотических мононуклеарных клеток костного мозга (ККМ) донора после обширной резекции печени.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. На крысах-самцах породы Wistar (n = 40) создавали модель адоптивного переноса здоровому реципиенту апоптотических ККМ (а-ККМ), изъятых у донора после обширной резекции печени. При проведении экспериментов животные были разделены на 5 групп. Четыре опытные группы с внутрибрюшинным введением реципиенту одинаковых доз: свежевыделенных ККМ (группа 1); ККМ, подвергнутых апоптозу в течение 48 часов путем хранения при t = 4–6 °C в растворе фосфатного буфера – PBS (группа 2) или в растворе Кустодиол HTK (группа 3); в группе 4 животным вводили PBS после хранения в нем ККМ. Контролем были животные с введением физиологического раствора (группа 5). Для выбора эффективных режимов индукции апоптоза ККМ, окрашенные 7AAD после инкубации в растворах, анализировали методом проточной цитометрии. Адресный перенос регенерационных сигналов реципиенту оценивали по митотической активности гепатоцитов в печени и канальцевого эпителия в почках, а также по интенсивности микроструктурных изменений в печени через 24, 48 и 72 часа после введения исследуемого материала.</p></sec><sec><title>Результаты</title><p>Результаты. Инкубирование ККМ в PBS и HTK в течение 48 часов при t = 4–6 °C обеспечивает наиболее эффективное накопление а-ККМ в состоянии раннего апоптоза. Показано, что а-ККМ при адоптивном переносе сохраняют способность адресной передачи регуляторных сигналов в печень, поддерживаемых процессом аутофагии. Установлено, что а-ККМ (группы 2 и 3) по сравнению с нативными ККМ (группа 1) при адоптивном переносе усиливают регенерационный потенциал печени за счет выраженного повышения активности процессов аутофагии и направленной инфильтрации печени иммуномодулирующими мононуклеарными клетками.</p></sec><sec><title>Заключение</title><p>Заключение. а-ККМ создают более прочную основу для выработки и осуществления адресной и эффективной регенерационной программы путем усиления процессов аутофагии и иммуномодулирующего воздействия на мононуклеарные клетки – переносчики регенерационных сигналов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: using an adoptive transfer model to study the cellular mechanisms involved in the formation of the initial stage of liver regeneration during intraperitoneal injection of a healthy recipient with apoptotic bone marrowderived mononuclear cells (BM-MNCs) from a donor after extended liver resection.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Male Wistar rats (n = 40) were used to create a model of adoptive transfer of apoptotic BM-MNCs (a-BM-MNCs) taken from the donor after extended liver resection to a healthy recipient. During the experiments, the animals were divided into five groups. Four experimental groups with intraperitoneal injection of the same doses to the recipient: freshly isolated BM-MNCs (group 1); BM-MNCs subjected to apoptosis for 48 hours by storage at t = 4–6 °C in phosphate-buffered saline (PBS) (group 2) or in a Custodiol HTK solution (group 3). In group 4, the animals were injected with PBS after storing BM-MNCs in it. The control animals were animals injected with saline (group 5). For selection of effective modes of apoptosis induction, BM-MNCs stained with 7AAD after incubation in solutions were analyzed by flow cytometry. Targeted transfer of regenerative signals to the recipient was assessed by the mitotic activity of hepatocytes in the liver and tubular epithelium in the kidneys, as well as by the intensity of microstructural changes in the liver 24, 48 and 72 hours after injection of the studied material.</p></sec><sec><title>Results</title><p>Results. BMC incubation in PBS and HTK for 48 hours at t = 4–6 °C provides the most effective accumulation of a-BM-MNCs in early apoptosis. It was shown that a-BM-MNCs retain the ability to target-focused transmission of regulatory signals to the liver supported by autophagy process during adoptive transfer. It was established that a-BM-MNCs (groups 2 and 3) in comparison to native BM-MNCs (group 1) at adoptive transfer increased the regenerative potential of the liver due to pronounced increase in the activity of autophagy processes and directed infiltration of immunomodulatory mononuclear cells in the liver.</p></sec><sec><title>Conclusion</title><p>Conclusion. a-BM-MNCs create a stronger basis for development and implementation of a targeted and effective regeneration program by enhancing autophagy processes and immunomodulatory effect on mononuclear cells, which are regenerative signal carriers.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>апоптоз</kwd><kwd>аутофагия</kwd><kwd>клетки костного мозга</kwd><kwd>печень</kwd><kwd>резекция</kwd><kwd>регенерация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>apoptosis</kwd><kwd>autophagy</kwd><kwd>bone marrow cells</kwd><kwd>liver</kwd><kwd>resection</kwd><kwd>regeneration</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаева АГ, Геворкян НМ, Зотиков ЕА. Роль лимфоцитов в оперативном изменении программы развития тканей. М.: Изд. РАМН, 2009. 107.</mixed-citation><mixed-citation xml:lang="en">Babaeva AG, Gevorkyan NM, Zotikov EA. Rol’ limfocitov v operativnom izmenenii programmy’ razvitiya tkanej. M.: Izd. RAMN, 2009. 107.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бабаева АГ, Тишевская НВ, Геворкян НМ. О морфогенетических свойствах РНК лимфоидных и стволовых клеток при восстановительных процессах. М.: Рос. акад. наук, Науч.-исслед. ин-т морфологии человека, 2016. 272.</mixed-citation><mixed-citation xml:lang="en">Babaeva AG, Tishevskaya NV, Gevorkyan NM. O morfogeneticheskikh svojstvakh RNK limfoidnykh i stvolovykh kletok pri vosstanovitel’nykh processax. M.: Ros. akad. nauk, Nauch.-issled. in-t morfologii cheloveka, 2016. 272.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Тишевская НВ, Бабаева АГ, Геворкян НМ. Роль лимфоцитарных РНК в межклеточном информационном обмене и регуляции регенеративных процессов. Росс. физиол. журнал им. И.М. Сеченова. 2016; 102 (11): 1280–1301.</mixed-citation><mixed-citation xml:lang="en">Tishevskaya NV, Babaeva AG, Gevorkyan NM. Rol’ limfocitarnykh RNK v mezhkletochnom informacionnom obmene i regulyacii regenerativnykh processov. Ross fiziol zhurnal im. I.M. Sechenova. 2016; 102 (11): 1280–1301.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho AB Quintannilha LF, Dias AS et al. Bone marrow multipotent mesenchymal stem cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells. 2008; 26: 1307–1314.</mixed-citation><mixed-citation xml:lang="en">Carvalho AB Quintannilha LF, Dias AS et al. Bone marrow multipotent mesenchymal stem cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells. 2008; 26: 1307–1314.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dai LJ, Li HY et al. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009; 2 (1): 16–25.</mixed-citation><mixed-citation xml:lang="en">Dai LJ, Li HY et al. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009; 2 (1): 16–25.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hodgkinson CP, Bareja A, Gomez JA, Dzau VJ. Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circ Res. 2016; 118: 95–107.</mixed-citation><mixed-citation xml:lang="en">Hodgkinson CP, Bareja A, Gomez JA, Dzau VJ. Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circ Res. 2016; 118: 95–107.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mansour S, Roy DC, Bouchard V et al. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design. J Cardiovasc Transl Res. 2010; 3: 153–159.</mixed-citation><mixed-citation xml:lang="en">Mansour S, Roy DC, Bouchard V et al. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design. J Cardiovasc Transl Res. 2010; 3: 153–159.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94: 92–95.</mixed-citation><mixed-citation xml:lang="en">Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94: 92–95.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004; 428: 664–668.</mixed-citation><mixed-citation xml:lang="en">Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004; 428: 664–668.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mirotsou M, Zhang Z, Deb A et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci. 2007; 104: 1643–1648.</mixed-citation><mixed-citation xml:lang="en">Mirotsou M, Zhang Z, Deb A et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci. 2007; 104: 1643–1648.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008; 103: 1204–1219.</mixed-citation><mixed-citation xml:lang="en">Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008; 103: 1204–1219.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016; 1416: 123–146.</mixed-citation><mixed-citation xml:lang="en">Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol. 2016; 1416: 123–146.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Korf-Klingebiel M, Kempf T, Sauer T et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J. 2008; 29: 2851–2858.</mixed-citation><mixed-citation xml:lang="en">Korf-Klingebiel M, Kempf T, Sauer T et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J. 2008; 29: 2851–2858.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998; 101: 890–898.</mixed-citation><mixed-citation xml:lang="en">Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998; 101: 890–898.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD. The dying stem cell hypothesis: immune odulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol. 2005; 46: 1799–1802.</mixed-citation><mixed-citation xml:lang="en">Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD. The dying stem cell hypothesis: immune odulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol. 2005; 46: 1799–1802.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239–257.</mixed-citation><mixed-citation xml:lang="en">Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239–257.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005; 22: 285–294.</mixed-citation><mixed-citation xml:lang="en">Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005; 22: 285–294.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol. 2007; 171: 2–8.</mixed-citation><mixed-citation xml:lang="en">Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol. 2007; 171: 2–8.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer E. Negative selection – clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol. 2003; 3: 383–391.</mixed-citation><mixed-citation xml:lang="en">Palmer E. Negative selection – clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol. 2003; 3: 383–391.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ren Y, Xie Y, Jiang G et al. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J Immunol. 2008; 180: 4978–4985.</mixed-citation><mixed-citation xml:lang="en">Ren Y, Xie Y, Jiang G et al. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J Immunol. 2008; 180: 4978–4985.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA. 2007; 104: 14080–14085.</mixed-citation><mixed-citation xml:lang="en">Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA. 2007; 104: 14080–14085.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology. 2011; 53: 306–316.</mixed-citation><mixed-citation xml:lang="en">Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology. 2011; 53: 306–316.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sirois I, Raymond MA, Brassard N et al. Caspase-3- dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication. Cell Death Differ. 2011; 18: 549–562.</mixed-citation><mixed-citation xml:lang="en">Sirois I, Raymond MA, Brassard N et al. Caspase-3- dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication. Cell Death Differ. 2011; 18: 549–562.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Q, Li F, Liu X et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011; 17: 860–866.</mixed-citation><mixed-citation xml:lang="en">Huang Q, Li F, Liu X et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011; 17: 860–866.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Beer L, Zimmermann M, Mitterbauer A et al. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep. 2015; 5: 16662.</mixed-citation><mixed-citation xml:lang="en">Beer L, Zimmermann M, Mitterbauer A et al. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep. 2015; 5: 16662.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ankersmit HJ, Hoetzenecker K, Dietl W et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest. 2009; 39: 445–456.</mixed-citation><mixed-citation xml:lang="en">Ankersmit HJ, Hoetzenecker K, Dietl W et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest. 2009; 39: 445–456.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Beer L, Mildner M, Gyöngyösi M, Ankersmit HJ. Peripheral blood mononuclear cell secretome for tissue repair Apoptosis. 2016; 21: 1336–1353. doi 10.1007/s10495-016-1292-8.</mixed-citation><mixed-citation xml:lang="en">Beer L, Mildner M, Gyöngyösi M, Ankersmit HJ. Peripheral blood mononuclear cell secretome for tissue repair Apoptosis. 2016; 21: 1336–1353. doi 10.1007/s10495-016-1292-8.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ельчанинов АВ, Фатхудинов ТХ. Регенерация печени млекопитающих: Межклеточные взаимодействия. М.: Наука, 2020. 126.</mixed-citation><mixed-citation xml:lang="en">Yel’chaninov AV, Fatkhudinov TKh. Regeneratsiya pecheni mlekopitayushchikh: Mezhkletochnyye vzaimodeystviya. M.: Nauka, 2020. 126.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Mougel F, Bonnefoy F, Kury-Paulin S et al. Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells. Diabetes Metab. 2012; 38: 531–537.</mixed-citation><mixed-citation xml:lang="en">Mougel F, Bonnefoy F, Kury-Paulin S et al. Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells. Diabetes Metab. 2012; 38: 531–537.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lin CW, Chen YS, Lin CC, Chen YJ, Lee PH, Kuo PL et al. Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy. Sci Rep. 2015 Oct 30; 5: 15807. doi: 10.1038/srep15807.</mixed-citation><mixed-citation xml:lang="en">Lin CW, Chen YS, Lin CC, Chen YJ, Lee PH, Kuo PL et al. Amiodarone as an autophagy promoter reduces liver injury and enhances liver regeneration and survival in mice after partial hepatectomy. Sci Rep. 2015 Oct 30; 5: 15807. doi: 10.1038/srep15807.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng Y, Wang B, Zhou H, Dang S, Jin M, Shi Y et al. Autophagy is required for maintenance of liver progenitor cell functionality. Cell Physiol Biochem. 2015; 36 (3): 1163–1174.</mixed-citation><mixed-citation xml:lang="en">Cheng Y, Wang B, Zhou H, Dang S, Jin M, Shi Y et al. Autophagy is required for maintenance of liver progenitor cell functionality. Cell Physiol Biochem. 2015; 36 (3): 1163–1174.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Газизов ИМ, Гумерова АА, Киясов АП. Апоптоз в регенерационном гистогенезе печени после частичной гепатэктомии у крыс. Гены и клетки. 2015; 10 (3):</mixed-citation><mixed-citation xml:lang="en">Gazizov IM, Gumerova AA, Kiyasov AP. Apoptosis in regenerative histogenesis of the liver after partial hepatectomy in rats. Genes and cells. 2015; 10 (3): 22–26.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">–26.</mixed-citation><mixed-citation xml:lang="en">Mongolov KhP, Plekhanov AN. Interrelation of apoptosis and liver regeneration in hepatic insufficiency after partial hepatectomy in an experiment. Acta Biomedica Scientifica. 2009; 3: 203–206.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Монголов ХП, Плеханов АН. Взаимосвязь апоптоза и регенерации печени при печеночной недостаточности после частичной гепатэктомии в эксперименте. Acta Biomedica Scientifica. 2009; 3: 203–206.</mixed-citation><mixed-citation xml:lang="en">Onishchenko NA, Fomenko YeV, Nikol’skaya AO, Gonikova ZZ, Shagidulin MYu, Balyasin MV i dr. K mekhanizmu aktivatsii vosstanovitel’nykh protsessov v pecheni pri ispol’zovanii obshchey RNK kletok kostnogo mozga. Vestnik transplantologii i iskusstvennykh organov. 2020; XXII (3): 134–142.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Онищенко НА, Фоменко ЕВ, Никольская АО, Гоникова ЗЗ, Шагидулин МЮ, Балясин МВ и др. К механизму активации восстановительных процессов в печени при использовании общей РНК клеток костного мозга. Вестник трансплантологии и искусственных органов. 2020; XXII (3): 134–142.</mixed-citation><mixed-citation xml:lang="en">Saas P, Daguindau E, Perruche S. Concise review: apoptotic cell-based therapies-rationale, preclinical results and future clinical developments. Stem Cells. 2016; 34 (6): 1464–1473.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Saas P, Daguindau E, Perruche S. Concise review: apoptotic cell-based therapies-rationale, preclinical results and future clinical developments. Stem Cells. 2016; 34 (6): 1464–1473.</mixed-citation><mixed-citation xml:lang="en">Notley CA, Brown MA, Wright GP, Ehrenstein MR. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol. 2011; 186: 4967–4972.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Notley CA, Brown MA, Wright GP, Ehrenstein MR. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol. 2011; 186: 4967–4972.</mixed-citation><mixed-citation xml:lang="en">Ruart M, Chavarria L, Campreciós G, Suárez-Herrera N, Montironi C, Guixé-Muntet S et al. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. J Hepatol. 2019 Mar; 70 (3): 458–469. doi: 10.1016/j.jhep.2018.10.015.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ruart M, Chavarria L, Campreciós G, Suárez-Herrera N, Montironi C, Guixé-Muntet S et al. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. J Hepatol. 2019 Mar; 70 (3): 458–469. doi: 10.1016/j.jhep.2018.10.015.</mixed-citation><mixed-citation xml:lang="en">Shen Y, Malik SA, Amir M, Kumar P, Cingolani F, Wen J et al. Decreased Hepatocyte Autophagy Leads to Synergistic IL-1β and TNF Mouse Liver Injury and Inflammation. Hepatology. 2020 Aug; 72 (2): 595–608. doi: 10.1002/hep.31209.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Shen Y, Malik SA, Amir M, Kumar P, Cingolani F, Wen J et al. Decreased Hepatocyte Autophagy Leads to Synergistic IL-1β and TNF Mouse Liver Injury and Inflammation. Hepatology. 2020 Aug; 72 (2): 595–608. doi: 10.1002/hep.31209.</mixed-citation><mixed-citation xml:lang="en">Xue R, Yang J, Jia L, Zhu X, Wu J, Zhu Y, Meng Q. Mitofusin2, as a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure. Front Pharmacol. 2019 May 31; 10:601. doi: 10.3389/fphar.2019.00601.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Xue R, Yang J, Jia L, Zhu X, Wu J, Zhu Y, Meng Q. Mitofusin2, as a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure. Front Pharmacol. 2019 May 31; 10:601. doi: 10.3389/fphar.2019.00601.</mixed-citation><mixed-citation xml:lang="en">Lv H, Fan X, Wang L, Feng H, Ci X. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy. Int J Biol Macromol. 2018 Nov; 119: 240–248. doi: 10.1016/j.ijbiomac.2018.07.101.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Lv H, Fan X, Wang L, Feng H, Ci X. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy. Int J Biol Macromol. 2018 Nov; 119: 240–248. doi: 10.1016/j.ijbiomac.2018.07.101.</mixed-citation><mixed-citation xml:lang="en">Lv H, Fan X, Wang L, Feng H, Ci X. Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy. Int J Biol Macromol. 2018 Nov; 119: 240–248. doi: 10.1016/j.ijbiomac.2018.07.101.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
